lobbying_activities: 2860579
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| id | filing_uuid | filing_type | registrant_name | registrant_id | client_name | filing_year | filing_period | issue_code | specific_issues | government_entities | income_amount | expense_amount | is_no_activity | is_termination | received_date |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2860579 | 4a03656d-9181-4c30-9f1d-c43721f91ad5 | Q3 | CRISPR THERAPEUTICS, INC. | 401105184 | CRISPR THERAPEUTICS, INC. | 2022 | third_quarter | MMM | General issues related to access for cell and gene therapies (no specific bills). | HOUSE OF REPRESENTATIVES,SENATE | 90000 | 0 | 0 | 2022-10-05T09:44:39-04:00 |